U.S. FDA Accepts Astellas' New Drug Application for Fezolinetant
Go back to U.S. FDA Accepts Astellas' New Drug Application for Fezolinetant| Astellas Pharma Inc Unsponsored ADR (AMEX: ALPMY) | Delayed: 14.42 +0.09 (0.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.33 | 52 Week High | $19.40 | |||
| Open | $14.89 | 52 Week Low | $12.50 | |||
| Day High | $14.89 | P/E | N/A | |||
| Day Low | $14.34 | EPS | $0.00 | |||
| Volume | 83,689 | |||||
